Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Article Type
Facet Toggle
Time Frame
Facet Toggle
BRIEFS
June 08, 2023
To meet many of today’s most pressing challenges, we need to find new solutions. But the fastest, cheapest, and most effective way to encourage high-impact innovation isn’t always obvious. Governments, philanthropists, and the private sector typically invest in research and development (R&D) by bett...
POLICY PAPERS
November 03, 2022
Pull financing is a powerful but underused mechanism for incentivising progress on hard-to-tackle social problems for which innovation or the take-up of innovation may be part of the solution. It should become part of the ongoing landscape for climate and development work. This paper sets out the sp...
Blog Post
November 03, 2022
In a new paper, we set out the case for using pull financing to solve problems that affect both development and climate outcomes by incentivising transformational change through technical innovation or massive-scale production and distribution of existing technologies. However, one big question our ...
Blog Post
December 20, 2021
As the year draws to a close, the temptation to claim wisdom from adversity and experience becomes irresistible. We did it last year, by exploring what we learnt while the world burned around us. 2021 was perhaps a marginal improvement: not quite the best of times, but not quite the worst of times, ...
Blog Post
November 10, 2021
COP26, like previous UN climate change conferences, has seen no shortage of “big round number” announcements aimed at making a splash in the press and signaling virtuous intent. Such announcements—be they promising $100 billion a year, demanding $1 trillion, or finding an additional £1 billion from ...
POLICY PAPERS
November 10, 2021
An increasing share of official development assistance is being used for climate-related activities. This trend is continuing despite the lack of comprehensive cost-effectiveness evidence to guide spending decisions and continuing concerns that few applications are effective or efficient mechanisms ...
Blog Post
October 21, 2021
After buying up the World’s vaccine supply to ensure they can protect their own populations, rich countries have found themselves struggling to use the vaccine surpluses they accumulated. One response has been to donate the spare doses to countries who need them more. This is laudable, and countries...
Blog Post
June 14, 2021
Many rich countries pre-ordered vast quantities of COVID-19 vaccines when they were still in development, enough to vaccinate their countries many times over. What is the right ‘price’ to pay for surplus vaccines, as opposed to those newly purchased? And how much of their value should be count...